BMY
BMY
NYSE · Pharmaceuticals

Bristol-Myers Squibb Co

S&P 500 Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield
$62.62
-0.44 (-0.70%)
Analyst Consensus
Hold
35
Analysts
Very High
Coverage
Buy 15 43%
Hold 18 51%
Sell 2 6%
Price Target
Analyst Price Target +178.7% upside
Low Target $130.78
Average Target $174.50
High Target $195.10
Current Price $62.62
Current
$62.62
Target
$174.50
$130.78 $174.50 avg $195.10
Scenario Analysis
Bear Case
$130.78
108.8%
Low target
Base Case
$174.50
+178.7%
Avg target
Bull Case
$195.10
+211.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$68.64
-8.8% from high
52-Week Low
$42.52
+47.3% from low
50-Day SMA
$55.66
+12.5% vs SMA
200-Day SMA
$49.00
+27.8% vs SMA
RSI (14)
74.1
Overbought
Target vs 52W High
$174.50
+154.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +194.2%